Does absolute neutrophilia predict early congestive heart failure after acute myocardial infarction? A cross-sectional study

Southern Medical Journal

Volumn 101, Issue 1, 2008, Pages 19-23

  Rashidi, Farid ^a   Rashidi, Arash ^b   Golmohamadi, Ali ^b   Hoseinzadeh, Eslam ^b   Mohammadi, Behzad ^b   Mirzajani, Houra ^b   Kheiri, Marziah ^b   Jamshidi, Peiman ^b  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

Congestive heart failure; Myocardial infarction; Neutrophilia

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME; HEPARIN; NITRATE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; FRAMINGHAM CRITERIA; GASTROINTESTINAL HEMORRHAGE; GENDER; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INFECTION; INJURY; KIDNEY FAILURE; KILLIP CLASS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHILIA; STATISTICAL SIGNIFICANCE; STEROID THERAPY; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEUTROPHILS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 37848999145     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31815d3e11     Document Type: Article

References (39)

1. Libman E. The importance of blood examinations in the recognition of thrombosis of coronary arteries and its sequelae. Am Heart J 1925;1:121-123.
2. Thomson Sp, gibbons RJ, Smars PA, et al. Intermantal value of the leuekocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infraction. Ann Intern Med 1995;122:335-341.
3. Friedman GD, Klastsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-1278.
4. Burr ML, Holliday RM, Fehily AM, et al. Haematological prognostic incidences after myocardial infarction: evidence from the Diet and Reinfarction Trial (DART). Eur Heart J 1992;13:166-170.
5. Fresco C, Carinci F, on behalf of the GISSI Investigators. Very early assessment of risk for in hospital death among 11,483 patients with acute myocardial infarction. Am Heart J 1999;138:1058-1064.
6. Ho KKL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22(suppl A):6A-13A.
7. Heart Failure Guidelines. Agency for Health Care Policy and Research publication No. 94-006612, Rockville, MD;US Department of health and human services: June 1994.
8. Kaul N, Siveski M, Hill M, et al. Free radicals and the heart. J Pharmacol Toxicol Methods 1993;30:55-67.
9. Giugliano D, Ceriello A, Paolisso G. Diabets mellitus, hypertension, and cardiovascular disease: which role for oxidative stress. Metabolism 1995;44:363-368.
10. Ypil WM, Tria R, Abad SJ. Absolute neutrophilia as predictor for the development of early onset congestive heart failure in patients admitted for acute myocardial infarction. PJCVN 2002;30:101-106.
11. Ali AS, Rybicki B, Alam M. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J 1999;138:1133-1139.
12. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience of 250 patients. Am J Cardiol 1967;20:457-464.
13. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
14. Furman MI, Becker RC, Yarzebski J, et al. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996;78:945-948.
15. Furman MI, Gore JM, Anderson FA, et al, GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-48.
16. Barron HV, Cannon CP, Murphy SA, et al. Association between white blood cell count, epicardal blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: Thrombolysis In Myocardial Infarction 10 substudy. Circulation 2000;102:2329-2334.
17. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radical in ischemic myocardial injury. J Mol Cell Cardiol 1989;21:1241-1251.
18. Jolly SR, Kane WJ, Hook BG, et al. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 1986;112:682-690.
19. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 1988;11:1309-1316.
20. Engler RL, Schmid-Schonbein GW, Paveles RS. Leukocute capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
21. Hansen PR. Role neutrophols in myocardial ischemia and reperfusion. Circulation 1995;91:1872-1885.
22. Ferrante RJ, Hobson RW 2nd, Miysaka M, et al. Inhibition of white blood cell adhesion at reperfusion decreases tissue damage in postischemic striated muscle. J Vasc Surg 1996;24:187-193.
23. de Cavanagh EM, Fraga CG, Ferder L, et al. Enalapril and Captopril enhance ontioxident defenses in mouse tissue. Am J Physiol Regulatory Integrative Comp Physiol 1997;272:514-518.
24. Bartosz M, Kedziora J, Bartosz G. Antioxdant properties of captopril. Free Radic Biol Med 1997;23:729-735.
25. Soejima H, Ogava H, Yasue H, et al. Angiotensin-converting enzyme inhibitor reduces monocyte chemo attractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999;34:983-988.
26. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
27. Kyne L, Hausdorff JM, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000;139:94:100.
28. Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction. J Am Coll Cardiol 2006;47:962-968.
29. Dhalla AR, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-514.
30. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-2420.
31. Marx N, Neuman Fj, Ott L, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997;30:165-170.
32. Wagner DR, Metiernan C, Sanders VJ, et al. Adenosine inhibits lipopolysacharide-induced secretion of tumor necrosis factor-alpha in the failing heart. Circulation 1998;97: 521-524.
33. Katz AM, Katz PB. Disease of the heart in works of Hippocrates. Br Heart J 1962;24:257-264.
34. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study Circulation 2003;107:1486-1491.
35. Maekawa Y, Anzai T, Yoshikawa T, et al. Prognostic significance of peripheral Monocytosis after reperfuses acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002;39: 241-246.
36. Nian M, Lee P, Khaper N, et al. Inflammatory cytokines and postmyocadial infarction remodeling. Circ Res 2004;94:1543-1553.
37. Valgimigli M, Ceconi C, Malaguti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of morality and new-onset heart failure in patients with acute myocardial infarction: the Cytokinase-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 2005;111:863-870.
38. Deten A, Volz HC, Briest W, et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction: experimental studies in rats. Cardiovasc Res 2002;55:329-340.
39. Irwin MW, Mak S, Mann DL, et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunction myocardium. Circulation 1999;99:1492-1498.